Physician profile
Tara M Morrison
NPI 1316919053
$7,194.15
in general payments reported to CMS, 2019-2025
32 companies · $813 in 2025
The $813 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $1,051 · 2021: $897 · 2022: $1,160 · 2023: $1,349 · 2024: $836 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,998.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,679.15 | 2019-2025 | |
| Glaxosmithkline, LLC. | $701.36 | 2021-2025 | Nucala |
| Genzyme Corporation | $687.24 | 2020-2025 | |
| Optinose US, INC. | $642.70 | 2019-2025 | |
| Intersect Ent, INC. | $481.67 | 2019-2021 | |
| Medtronic, INC. | $448.55 | 2022-2025 | Propel, Sinuva, Nuvent |
| Regeneron Healthcare Solutions, INC. | $431.10 | 2019-2024 | Dupixent |
| Inspire Medical Systems, INC. | $356.43 | 2022-2025 | Inspire |
| Stryker Corporation | $355.60 | 2019-2022 | |
| Acclarent, INC | $305.53 | 2019-2024 | Trudi Nav Cable, Acclarent Aera |
| Alk-Abello, INC | $179.42 | 2019-2022 | |
| Arrinex, INC. | $131.44 | 2019 | |
| Spirair, INC. | $120.21 | 2024-2025 | Septalign |
| Ars Pharmaceuticals Operations, INC. | $112.39 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $89.45 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $75.80 | 2023-2025 | Tezspire, Fasenra |
| Kaleo, INC. | $66.62 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.22 | 2021-2023 | |
| Abbvie INC. | $29.99 | 2023 | |
| Arbor Pharmaceuticals, INC. | $29.25 | 2020 | |
| Integra Lifesciences Corporation | $25.27 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Horizon Therapeutics Plc | $24.39 | 2019 | |
| Leo Pharma INC. | $23.66 | 2022 | |
| Eyevance Pharmaceuticals LLC | $22.38 | 2021 | |
| Hikma Pharmaceuticals USA | $22.38 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $19.15 | 2022 | |
| Hologic Sales and Service, LLC | $18.00 | 2024 | Coolseal Generator |
| Smith+Nephew, INC. | $17.94 | 2025 | Tula |
| Olympus America INC. | $16.72 | 2023 | |
| Sunovion Pharmaceuticals INC. | $14.39 | 2019 | |
| Genentech USA, INC. | $14.25 | 2022 | |
| Lilly USA, LLC | $13.50 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.